المؤلفون: Chen, Ching-Hsien, Statt, Sarah, Chiu, Chun-Lung, Thai, Philip, Arif, Muhammad, Adler, Kenneth B, Wu, Reen

المصدر: American journal of respiratory and critical care medicine. 190(10)

مصطلحات موضوعية: Animals, Cell Culture Techniques, Cell Line, Tumor, Disease Models, Animal, Humans, Intracellular Signaling Peptides and Proteins: metabolism, Lung Neoplasms: drug therapy, metabolism, pathology, Membrane Proteins: metabolism, Mice, Phosphatidylinositol 3-Kinase: metabolism, Phosphatidylinositol Phosphates: metabolism, Phosphorylation: physiology, Protein Kinase Inhibitors: therapeutic use, Quinazolines: therapeutic use, Signal Transduction: physiology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/7jm9t4vvTest

المؤلفون: Grunenberg, Alexander, Kaiser, Lisa M., Woelfle, Stephanie, Schmelzle, Birgit, Viardot, Andreas, Möller, Peter, Barth, Thomas F. E., Muche, Rainer, Dreyhaupt, Jens, Raderer, Markus, Kiesewetter, Barbara, Buske, Christian

المصدر: http://lobid.org/resources/99370673697106441Test#!, 21(1):749.

مصطلحات موضوعية: Pyrimidines/pharmacology [MeSH], Antibodies, Monoclonal/therapeutic use [MeSH], Lymphoma, B-Cell, Marginal Zone/drug therapy [MeSH], Study Protocol, Humans [MeSH], Prospective Studies [MeSH], Monoclonal/pharmacology [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], PI3K inhibitor, Medical and radiation oncology, Pyrimidines/therapeutic use [MeSH], Copanlisib, Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Marginal zone lymphoma, Quinazolines/pharmacology [MeSH], Phosphoinositide-3 Kinase Inhibitors/therapeutic use [MeSH], Quinazolines/therapeutic use [MeSH], Rituximab

العلاقة: https://repository.publisso.de/resource/frl:6462819Test; https://doi.org/10.1186/s12885-021-08464-6Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243426Test/

الإتاحة: https://doi.org/10.1186/s12885-021-08464-6Test
https://repository.publisso.de/resource/frl:6462819Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243426Test/

المؤلفون: Steendam, Christi M J, Peric, Robert, van Walree, Nico C, Youssef, Magdolen, Schramel, Franz M N H, Brocken, Pepijn, van Putten, John W G, van der Noort, Vincent, Veerman, G D Marijn, Koolen, Stijn L W, Groen, Harry J M, Dingemans, Anne-Marie C, Mathijssen, Ron H J, Smit, Egbert F, Aerts, Joachim G J V

المصدر: NVALT Study Group , Steendam , C M J , Peric , R , van Walree , N C , Youssef , M , Schramel , F M N H , Brocken , P , van Putten , J W G , van der Noort , V , Veerman , G D M , Koolen , S L W , Groen , H J M , Dingemans , A-M C , Mathijssen , R H J , Smit , E F & Aerts , J G J V 2021 , ' Randomized phase III study of docetaxel versus docetaxel ....

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carcinoma, Non-Small-Cell Lung/drug therapy, Disease-Free Survival, Docetaxel/therapeutic use, Erlotinib Hydrochloride/therapeutic use, Humans, Lung Neoplasms/drug therapy, Quinazolines/therapeutic use, Taxoids/therapeutic use

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/805bc8e6-35d1-4986-a82e-137b980eba50Test

الإتاحة: https://doi.org/10.1016/j.lungcan.2021.08.002Test
https://hdl.handle.net/11370/805bc8e6-35d1-4986-a82e-137b980eba50Test
https://research.rug.nl/en/publications/805bc8e6-35d1-4986-a82e-137b980eba50Test
https://pure.rug.nl/ws/files/190741747/Randomized_phase_III_study_of_docetaxel_versus_docetaxel_plus_intercalated_erlotinib_in_patients_with_relapsed_non_squamous_non_small_cell_lung_carcinoma.pdfTest

المؤلفون: Lenz, Georg, Hawkes, Eliza, Verhoef, Gregor, Haioun, Corinne, Thye Lim, Soon, Seog Heo, Dae, Ardeshna, Kirit, Chong, Geoffrey, Haaber, Jacob, Shi, Wei, Gorbatchevsky, Igor, Lippert, Susanne, Hiemeyer, Florian, Piraino, Paolo, Beckmann, Georg, Peña, Carol, Buvaylo, Viktoriya, Childs, Barrett H., Salles, Gilles

المصدر: http://lobid.org/resources/99370672770606441Test#!, 34(8):2184-2197.

مصطلحات موضوعية: CD79 Antigens/genetics [MeSH], Female [MeSH], Mutation [MeSH], Aged, 80 and over [MeSH], Lymphoma, Large B-Cell, Diffuse/genetics [MeSH], Aged [MeSH], Diffuse/drug therapy [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Quinazolines/adverse effects [MeSH], Recurrence [MeSH], Article, Pyrimidines/therapeutic use [MeSH], Male [MeSH], Pyrimidines/adverse effects [MeSH], B-cell lymphoma, Phosphoinositide-3 Kinase Inhibitors/therapeutic use [MeSH], Targeted therapies, Diffuse/mortality [MeSH], Quinazolines/therapeutic use [MeSH], High-Throughput Nucleotide Sequencing [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6471026Test; https://doi.org/10.1038/s41375-020-0743-yTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387311Test/

الإتاحة: https://doi.org/10.1038/s41375-020-0743-yTest
https://repository.publisso.de/resource/frl:6471026Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387311Test/

المؤلفون: Derigs, Patrick, Radujkovic, Aleksandar, Schubert, Maria-Luisa, Schnitzler, Paul, Schöning, Tilman, Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O., Luft, Thomas, Dreger, Peter, Schmitt, Michael

المصدر: http://lobid.org/resources/99370678538206441Test#!, 100(8):2087-2093.

مصطلحات موضوعية: Hematopoietic-cell transplantation, Aged [MeSH], Latent Infection/prevention, Letermovir, Cytomegalovirus Infections/prevention, Transplantation, Homologous/adverse effects [MeSH], Cohort Studies [MeSH], Acetates/therapeutic use [MeSH], Original Article, Cytomegalovirus, Male [MeSH], Cytomegalovirus/drug effects [MeSH], Female [MeSH], Homologous/methods [MeSH], Adult [MeSH], Virus Activation/drug effects [MeSH], Humans [MeSH], Middle Aged [MeSH], Real-world data, Hematopoietic Stem Cell Transplantation/adverse effects [MeSH], Resource utilization, Young Adult [MeSH], Antiviral Agents/therapeutic use [MeSH], Hematopoietic Stem Cell Transplantation/methods [MeSH], Quinazolines/therapeutic use [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6467032Test; https://doi.org/10.1007/s00277-020-04362-2Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285358Test/

الإتاحة: https://doi.org/10.1007/s00277-020-04362-2Test
https://repository.publisso.de/resource/frl:6467032Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285358Test/

المؤلفون: Edvinsson, Lars

المصدر: Läkartidningen. 107(50):11-3208

مصطلحات موضوعية: Azepines: therapeutic use, Calcitonin Gene-Related Peptide: metabolism, Dipeptides: therapeutic use, Imidazoles: therapeutic use, Migraine Disorders: drug therapy, Migraine Disorders: metabolism, Migraine Disorders: physiopathology, Quinazolines: therapeutic use, Medicin och hälsovetenskap, Klinisk medicin, Annan klinisk medicin, Medical and Health Sciences, Clinical Medicine, Other Clinical Medicine

وصف الملف: electronic

الوصول الحر: https://lup.lub.lu.se/record/1832308Test
https://portal.research.lu.se/files/5365692/1848706.pdfTest
http://www.ncbi.nlm.nih.gov/pubmed/21294334?dopt=AbstractTest

المؤلفون: Robert Peric, Vincent van der Noort, Harry J.M. Groen, Anne-Marie C. Dingemans, Nico van Walree, Franz M.N.H. Schramel, Christi M.J. Steendam, Pepijn Brocken, Stijn L.W. Koolen, G.D. Marijn Veerman, John W. G. van Putten, Ron H.J. Mathijssen, Egbert F. Smit, Joachim G.J.V. Aerts, Magdolen Youssef

المساهمون: Pulmonary Medicine, Medical Oncology, Pharmacy, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)

المصدر: Lung Cancer, 160, 44-49. Elsevier Ireland Ltd
Lung Cancer, 160, 44-49. ELSEVIER IRELAND LTD

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Erlotinib Hydrochloride/therapeutic use, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Combination therapy, Carcinoma, Non-Small-Cell Lung/drug therapy, Quinazolines/therapeutic use, Taxoids/therapeutic use, EGFR, Non-Small-Cell Lung/drug therapy, Docetaxel, Gastroenterology, Disease-Free Survival, Erlotinib Hydrochloride, SDG 3 - Good Health and Well-being, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Humans, Progression-free survival, Epidermal growth factor receptor, CANCER PATIENTS, Lung Neoplasms/drug therapy, COMBINATION, neoplasms, SCHEDULE, Docetaxel/therapeutic use, biology, PLASMA, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Hazard ratio, CHEMOTHERAPY, medicine.disease, Oncology, Erlotinib, Toxicity, biology.protein, Quinazolines, Taxoids, business, Non-small-cell lung cancer, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1412cde3a5dc0bde1bb210d253e089Test
https://doi.org/10.1016/j.lungcan.2021.08.002Test

المساهمون: Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Byoung Chul Cho, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, David Planchard, Wu-Chou Su, Jhanelle E. Gray, Siow-Ming Lee, Rachel Hodge, Marcelo Marotti, Yuri Rukazenkov, Suresh S. Ramalingam, FLAURA Investigators, Cho, Byoung Chul

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/genetics, Non-Small-Cell Lung/mortality, Disease-Free Survival, Double-Blind Method, ErbB Receptors/genetics, Erlotinib Hydrochloride/therapeutic use, Female, Gefitinib, Humans, Kaplan-Meier Estimate, Lung Neoplasms/drug therapy, Lung Neoplasms/genetics, Lung Neoplasms/mortality, Male, Middle Aged, Mutation, Piperazines/adverse effects, Piperazines/therapeutic use, Protein Kinase Inhibitors/adverse effects, Protein Kinase Inhibitors/therapeutic use, Protein-Tyrosine Kinases/antagonists & inhibitors, Quinazolines/therapeutic use, Survival Rate

العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2019-00420; https://ir.ymlib.yonsei.ac.kr/handle/22282913/167634Test; T201805531; NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

الإتاحة: https://doi.org/10.1056/NEJMoa1713137Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/167634Test

المساهمون: College of Medicine, Dept. of Internal Medicine, Michael F. Press, Catherine E. Ellis, Robert C. Gagnon, Tobias J. Grob, Marc Buyse, Ivonne Villalobos, Zhiyong Liang, Shafei Wu, Yung-Jue Bang, Shu-Kui Qin, Hyun Cheol, Chung, Jianming Xu, Joon Oh Park, Krzysztof Jeziorski, Karen Afenjar, Yanling Ma, Monica C. Estrada, Douglas M. Robinson, Stefan J. Scherer, Guido Sauter, J. Randolph Hecht, Dennis J. Slamon, Chung, Hyun Cheol

مصطلحات موضوعية: Adenocarcinoma/drug therapy, Adenocarcinoma/metabolism, Adenocarcinoma/mortality, Adult, Aged, 80 and over, Esophageal Neoplasms/drug therapy, Esophageal Neoplasms/genetics, Esophageal Neoplasms/metabolism, Esophageal Neoplasms/mortality, Female, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Male, Middle Aged, Protein Kinase Inhibitors/therapeutic use, Quinazolines/therapeutic use, Receptor, ErbB-2/antagonists & inhibitors, ErbB-2/genetics, ErbB-2/metabolism, Stomach Neoplasms/drug therapy, Stomach Neoplasms/genetics, Stomach Neoplasms/metabolism, Stomach Neoplasms/mortality, Treatment Outcome, Young Adult

العلاقة: MOLECULAR CANCER THERAPEUTICS; J02254; OAK-2017-04870; https://ir.ymlib.yonsei.ac.kr/handle/22282913/160796Test; T201703329; MOLECULAR CANCER THERAPEUTICS, Vol.16(1) : 228-238, 2017

الإتاحة: https://doi.org/10.1158/1535-7163.MCT-15-0887Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160796Test

المساهمون: College of Medicine, Dept. of Internal Medicine, Dong-Wan Kim, Edward B. Garon, Aminah Jatoi, Dorothy M. Keefe, Mario E. Lacouturee, Stephen Sonis, Diana Gernhardt, Tao Wangg, Nagdeep Giri, Jim P. Doherty, Sashi Nadanaciva, Joseph O�섴onnell, Eric Sbar, Byoung Chul Cho, Cho, Byoung Chul

مصطلحات موضوعية: Carcinoma, Non-Small-Cell Lung/drug therapy, Cohort Studies, Disease-Free Survival, Dose-Response Relationship, Drug, Female, Humans, Lung Neoplasms/drug therapy, Male, Middle Aged, Mutation, Neoplasm Staging, Quinazolines/therapeutic use, Quinazolinones/administration & dosage, Quinazolinones/adverse effects, Quinazolinones/blood, Quinazolinones/pharmacokinetics, Receptor, Epidermal Growth Factor/antagonists & inhibitors, Epidermal Growth Factor/genetics, Republic of Korea, Treatment Outcome, Dacomitinib, Dose interruption, Non-small-cell lung cancer, Pharmacokinetic, Supportive care

العلاقة: LUNG CANCER; J02174; OAK-2017-02491; https://ir.ymlib.yonsei.ac.kr/handle/22282913/154294Test; http://www.sciencedirect.com/science/article/pii/S0169500217300326Test; T201701983; LUNG CANCER, Vol.106 : 76-82, 2017

الإتاحة: https://doi.org/10.1016/j.lungcan.2017.01.021Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/154294Test
http://www.sciencedirect.com/science/article/pii/S0169500217300326Test